Published in Protein Sci on March 01, 2007
Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep (2009) 1.42
Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J Biol Chem (2008) 1.33
Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling. Structure (2009) 1.29
Nectin ectodomain structures reveal a canonical adhesive interface. Nat Struct Mol Biol (2012) 1.04
Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. Cell Adh Migr (2012) 1.02
Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J Virol (2011) 1.00
Ephrin-Eph signaling in embryonic tissue separation. Cell Adh Migr (2014) 0.98
Affinity, avidity, and kinetics of target sequence binding to LC8 dynein light chain isoforms. J Biol Chem (2010) 0.90
Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode. Nat Commun (2015) 0.89
A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5. Dev Neurobiol (2008) 0.88
Toward the semisynthesis of multidomain transmembrane receptors: modification of Eph tyrosine kinases. Protein Sci (2008) 0.86
Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor. ACS Med Chem Lett (2013) 0.83
Reverse signaling via a glycosyl-phosphatidylinositol-linked ephrin prevents midline crossing by migratory neurons during embryonic development in Manduca. J Neurosci (2008) 0.79
Note: Model identification and analysis of bivalent analyte surface plasmon resonance data. Rev Sci Instrum (2015) 0.75
Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist. Sci Rep (2017) 0.75
Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol (2005) 7.14
The ephrins and Eph receptors in neural development. Annu Rev Neurosci (1998) 5.07
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci (2004) 4.22
Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science (1994) 3.53
Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell (2004) 3.11
In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell (1995) 2.68
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene (2000) 2.46
Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene (2000) 2.45
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene (2002) 2.41
Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev (1998) 2.38
Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell (1997) 2.31
'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci (2003) 2.17
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem (2004) 2.17
Eph signaling: a structural view. Trends Neurosci (2003) 1.74
Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J Biol Chem (1998) 1.32
Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition. Structure (2005) 1.18
Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor. J Biol Chem (1997) 1.14
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. Clin Cancer Res (1999) 1.13
Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res (1998) 1.06
Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J Biol Chem (2005) 1.01
Temporally compartmentalized expression of ephrin-B2 during renal glomerular development. J Am Soc Nephrol (2001) 0.91
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci (2004) 4.22
Human genomes as email attachments. Bioinformatics (2008) 3.59
Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell (2005) 3.34
Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int (2004) 3.06
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol (2011) 2.75
A wireless passive pressure microsensor fabricated in HTCC MEMS technology for harsh environments. Sensors (Basel) (2013) 2.44
Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol (2007) 2.24
Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A (2008) 2.08
Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol (2012) 1.84
Architecture of Eph receptor clusters. Proc Natl Acad Sci U S A (2010) 1.82
Undulatory swimming in sand: subsurface locomotion of the sandfish lizard. Science (2009) 1.79
Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J (2003) 1.78
Eph signaling: a structural view. Trends Neurosci (2003) 1.74
Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev (2012) 1.72
B7-H3 over expression in prostate cancer promotes tumor cell progression. J Urol (2011) 1.71
Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer (2009) 1.68
Structure of GABARAP in two conformations: implications for GABA(A) receptor localization and tubulin binding. Neuron (2002) 1.66
Structure of the semaphorin-3A receptor binding module. Neuron (2003) 1.63
New colchicinoids from a native Jordanian meadow saffron, colchicum brachyphyllum: isolation of the first naturally occurring dextrorotatory colchicinoid. J Nat Prod (2005) 1.59
Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci U S A (2008) 1.58
Identification of reptilian and amphibian blood meals from mosquitoes in an eastern equine encephalomyelitis virus focus in central Alabama. Am J Trop Med Hyg (2004) 1.57
Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects. Breast Cancer Res Treat (2010) 1.57
Structural and functional characterization of the Pseudomonas hydroperoxide resistance protein Ohr. EMBO J (2002) 1.56
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
A semisynthetic Eph receptor tyrosine kinase provides insight into ligand-induced kinase activation. Chem Biol (2011) 1.54
Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells (2005) 1.45
Hobbes: optimized gram-based methods for efficient read alignment. Nucleic Acids Res (2011) 1.44
Assessment of NER solutions against the first and second CALBC Silver Standard Corpus. J Biomed Semantics (2011) 1.43
Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep (2009) 1.42
Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell (2010) 1.39
Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro. Evid Based Complement Alternat Med (2011) 1.39
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell Res (2010) 1.36
Ferroelectric-field-effect-enhanced electroresistance in metal/ferroelectric/semiconductor tunnel junctions. Nat Mater (2013) 1.33
Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer (2006) 1.32
Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat Struct Mol Biol (2006) 1.31
Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J Biol Chem (2005) 1.27
Structural and functional features of the Escherichia coli hydroperoxide resistance protein OsmC. Protein Sci (2003) 1.26
Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol (2011) 1.25
Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis (2010) 1.24
Designing and encoding models for synthetic biology. J R Soc Interface (2009) 1.23
Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation. J Cell Biol (2008) 1.21
Down-regulation of a SILENT INFORMATION REGULATOR2-related histone deacetylase gene, OsSRT1, induces DNA fragmentation and cell death in rice. Plant Physiol (2007) 1.21
Molecular mechanisms underlying the analgesic property of intrathecal dexmedetomidine and its neurotoxicity evaluation: an in vivo and in vitro experimental study. PLoS One (2013) 1.21
Increased neuroglobin levels in the cerebral cortex and serum after ischemia-reperfusion insults. Brain Res (2006) 1.20
Expanding pyrimidine diphosphosugar libraries via structure-based nucleotidylyltransferase engineering. Proc Natl Acad Sci U S A (2002) 1.19
Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition. Structure (2005) 1.18
The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer. J Surg Oncol (2009) 1.17
Endometriosis of the lung: report of a case and literature review. Eur J Med Res (2013) 1.15
High-efficiency fluorescent organic light-emitting devices using sensitizing hosts with a small singlet-triplet exchange energy. Adv Mater (2014) 1.13
MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Cell Signal (2013) 1.12
Design of anticancer prodrugs for reductive activation. Med Res Rev (2009) 1.12
Biological network extraction from scientific literature: state of the art and challenges. Brief Bioinform (2013) 1.12
Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J Ethnopharmacol (2009) 1.11
Dopamine as a carbon source: the controlled synthesis of hollow carbon spheres and yolk-structured carbon nanocomposites. Angew Chem Int Ed Engl (2011) 1.11
Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. Antimicrob Agents Chemother (2009) 1.11
Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol (2009) 1.10
Motor and nonmotor domains in the monkey dentate. Ann N Y Acad Sci (2002) 1.10
Spectroscopic rationale for efficient stimulated-emission depletion microscopy fluorophores. J Am Chem Soc (2010) 1.10
Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. J Neurosci Res (2006) 1.08
Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression. J Biol Chem (2003) 1.07
Influenza vaccination coverage among health care personnel--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.07
Eph receptors and ephrins. Int J Biochem Cell Biol (2003) 1.06
West Nile virus infection in mosquitoes in the mid-south USA, 2002-2005. J Med Entomol (2007) 1.06
Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J Proteome Res (2010) 1.05
Crystal structure of the ephrin-B1 ectodomain: implications for receptor recognition and signaling. Biochemistry (2005) 1.04
Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp Neurol (2002) 1.04
Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem (2009) 1.03
Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol. Psychopharmacology (Berl) (2009) 1.02
BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro. J Cancer Res Clin Oncol (2012) 1.02
A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res (2013) 1.02
Interactive and fuzzy search: a dynamic way to explore MEDLINE. Bioinformatics (2010) 1.01
Substrate specificity of NovM: implications for novobiocin biosynthesis and glycorandomization. Org Lett (2003) 1.01
Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. J Biol Chem (2005) 1.01
Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer (2014) 1.01
Influence of conformation on conductance of biphenyl-dithiol single-molecule contacts. Nano Lett (2010) 1.00
Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis. Arch Gynecol Obstet (2013) 0.99
Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Pharm Res (2007) 0.99
Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. PLoS One (2010) 0.99
Regulation of the histone acetyltransferase activity of hMOF via autoacetylation of Lys274. Cell Res (2011) 0.99
Nitroreductase: a prodrug-activating enzyme for cancer gene therapy. Clin Exp Pharmacol Physiol (2004) 0.99
Multi-objective optimization of bioethanol production during cold enzyme starch hydrolysis in very high gravity cassava mash. Bioresour Technol (2011) 0.99
Differentiation of the midbrain dopaminergic pathways during mouse development. J Comp Neurol (2004) 0.99
Fiber-optic intrinsic distributed acoustic emission sensor for large structure health monitoring. Opt Lett (2009) 0.99
BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PLoS One (2013) 0.98
1-(4-Fluoro-phen-yl)-2-(1H-imidazol-1-yl)ethanone. Acta Crystallogr Sect E Struct Rep Online (2011) 0.98
Porcine reproductive and respiratory syndrome virus induces autophagy to promote virus replication. Autophagy (2012) 0.98
Distribution of EphA5 receptor protein in the developing and adult mouse nervous system. J Comp Neurol (2009) 0.98
Crystal structures of Lgr4 and its complex with R-spondin1. Structure (2013) 0.97
Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection. Ann Surg Oncol (2008) 0.97
Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis. Electrophoresis (2009) 0.97
MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett (2014) 0.96
P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer. PLoS One (2012) 0.96
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo. Arch Virol (2012) 0.96
Efficient amidation from carboxylic acids and azides via selenocarboxylates: application to the coupling of amino acids and peptides with azides. J Org Chem (2007) 0.96